New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...

Newark Mayor Ras Baraka, a NJ gubernatorial candidate, joins “The Weeknight” to discuss his arrest for visiting an ICE ...

Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by Verastem ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

The human body and its organs are composed of a wide variety of cell types. Although all cells contain the same genes, they ...

Proof-of-mechanism has been established for TNG260 based on pharmacodynamic data from on-treatment patient biopsies, with ...

Baraka was arrested as he protested the opening of an ICE detention center. CBS News New York's Alecia Reid reports.

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumorsInterim analysis from ...

PMV Pharma ended the first quarter with $165.8 million in cash, cash equivalents, and marketable securities, compared to $183.3 million as of December 31, 2024. Net cash used in operations was $18.3 ...

The KRAS G12D mutation is the most common oncogenic KRAS variant, identified in approximately 34% of pancreatic ductal adenocarcinoma cases, 12% of colorectal cancers and 4% of lung adenocarcinomas.